跳至主要内容
临床试验/IRCT20230729058953N1
IRCT20230729058953N1招募中3 期

????? ????? ?? ???????: (?????? 2 ??)Aspirin versus dual antiplatelet therapy-aspirin and clopidogrel- in patients with minor acute ischemic stroke receiving intravenous thrombolytic therapy: a double blind randomized clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Over the age of 18 years
  • individuals with acute ischemic stroke symptoms of disabling with NIHSS less than 5 which are not prohibited for receiving venous thrombolysis and double antiplatelet (aspirin and clopidogrel combination) according to the protocol.

排除标准

  • Patients with atrial fibrillation(AF) rhythm
  • A patient who is already on dual antiplatelet therapy
  • ICH (intracranial hemorrhage) symptomatic after receiving intravenous thrombolysis.

研究者

相似试验